Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. 2008

Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
Department of Cardiovascular Surgery, University of Okayama Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. gmd16008@cc-okayama-u.ac.jp

BACKGROUND Coronary ischemia-reperfusion (I/R) injury causes cardiomyocyte necrosis in a multi-step process that includes an inflammatory reaction. A recent study has suggested that high-mobility group box 1 (HMGB1) is a late mediator of lethal sepsis and an early mediator of inflammation and necrosis following I/R injury. In the present study a neutralizing monoclonal antibody (mAb) for HMGB1 was used to clarify the role of HMGB1 in cardiac I/R injury. RESULTS Rats underwent 30 min of left coronary artery occlusion followed by 60 min reperfusion. An intravenous injection of anti-HMGB1 mAb or control IgG was administered just before reperfusion. The infarct size was enlarged in the anti-HMGB1 mAb group in comparison with the control group (p<0.05). The treatment of anti-HMGB1 mAb significantly increased the plasma troponin-T and norepinephrine (NE) content in the heart in comparison with the control (p<0.05). Moreover, the production of dihydroxyphenylglycol was reduced in the anti-HMGB1-treated group (p<0.05). CONCLUSIONS This study shows for the first time the effects of treatment with neutralizing anti-HMGB1 mAb on I/R injury in the rat heart. The findings support the novel view that I/R-induced HMGB1 may be an important factor in the modulation of interstitial NE.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015428 Myocardial Reperfusion Injury Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion Injury, Myocardial,Injury, Myocardial Reperfusion,Myocardial Ischemic Reperfusion Injury,Injuries, Myocardial Reperfusion,Myocardial Reperfusion Injuries,Reperfusion Injuries, Myocardial

Related Publications

Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
January 2001, Cardiovascular drugs and therapy,
Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
February 2004, Journal of cardiovascular pharmacology,
Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
April 2011, Sheng li ke xue jin zhan [Progress in physiology],
Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
July 2013, The Journal of surgical research,
Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
April 2015, International journal of cardiology,
Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
November 2010, Journal of the American Society of Nephrology : JASN,
Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
April 2001, Experimental biology and medicine (Maywood, N.J.),
Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
October 2021, Biochemical and biophysical research communications,
Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
October 1993, Zhonghua xin xue guan bing za zhi,
Susumu Oozawa, and Shuji Mori, and Toru Kanke, and Hideo Takahashi, and Keyue Liu, and Yasuko Tomono, and Masato Asanuma, and Ikuko Miyazaki, and Masahiro Nishibori, and Shunji Sano
November 1992, Methods and findings in experimental and clinical pharmacology,
Copied contents to your clipboard!